DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trileptal (Oxcarbazepine) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (7)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Trileptal (Oxcarbazepine) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Trileptal side effects in 11 year old male

Reported by a physician from China on 2012-07-20

Patient: 11 year old male

Reactions: Myoclonus, Leukodystrophy, Tremor

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Trileptal
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-11-24

Trileptal
    Dosage: 0.45 g, bid
    Administration route: Oral
    End date: 2012-05-29

Other drugs received by patient: Lamotrigine; Valproate Sodium



Possible Trileptal side effects in 11 year old male

Reported by a physician from China on 2012-06-11

Patient: 11 year old male

Reactions: Myoclonus, Leukodystrophy, Tremor

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Trileptal
    Dosage: 0.45 g, bid
    Administration route: Oral
    End date: 2012-05-29

Trileptal
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-11-24

Other drugs received by patient: Lamotrigine; Valproate Sodium



Possible Trileptal side effects in male

Reported by a consumer/non-health professional from Mexico on 2012-04-18

Patient: male

Reactions: Diabetes Mellitus, Pain, Poor Peripheral Circulation, Extremity Necrosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Trileptal

Other drugs received by patient: Insulin



Possible Trileptal side effects in male

Reported by a consumer/non-health professional from United States on 2012-02-02

Patient: male

Reactions: Bedridden, Head Injury, Abasia, Fall, Onychomadesis, Loss of Consciousness, Limb Injury, Drug Withdrawal Convulsions, Withdrawal Syndrome, Back Injury

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Trileptal



Possible Trileptal side effects in male

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-01-17

Patient: male

Reactions: Dyspnoea, Interstitial Lung Disease, Oxygen Saturation Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Valproate Sodium
    Administration route: Oral
    Indication: Epilepsy

Trileptal
    Dosage: 750 mg and 650 mg daily
    Administration route: Oral
    Indication: Epilepsy

Topamax
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Zyprexa; Paroxetine HCL



Possible Trileptal side effects in male

Reported by a physician from Sweden on 2011-12-02

Patient: male

Reactions: Fatigue, Disturbance in Attention, Mood Swings, Epilepsy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Trileptal

Other drugs received by patient: Valproate Sodium



Possible Trileptal side effects in male

Reported by a physician from France on 2011-11-15

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Lymphadenopathy, Blood Creatine Phosphokinase Increased, Respiratory Disorder, High Density Lipoprotein Increased, Urinary Incontinence, Visual Acuity Reduced, Ulcerative Keratitis, Pyrexia, Transaminases Increased, Obstructive Uropathy, C-Reactive Protein Increased, Dermatitis Bullous, Acute Respiratory Distress Syndrome, Mucous Membrane Disorder, Cough, Back Pain, Medical Device Complication, Dysphagia, Toxic Epidermal Necrolysis, Corneal Opacity, Prothrombin Time Ratio Decreased, Blood Creatine Phosphokinase MB Increased, Heart Rate Decreased, Rash Erythematous, Renal Colic, Corneal Neovascularisation, Skin Exfoliation, Eye Discharge, Scab, Symblepharon, Nephrolithiasis, Photophobia, Microlithiasis, Bone Marrow Failure, Thrombocytopenia, Renal Failure Acute, Cataract, Epilepsy, Iris Adhesions, Alopecia, Lacrimation Decreased, Gait Disturbance, Asthenia, Leukopenia

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Depakene
    Dosage: 1 g daily
    Administration route: Oral
    Indication: Partial Seizures
    Start date: 2004-11-23
    End date: 2004-11-23

Trileptal
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: Partial Seizures
    Start date: 2005-02-14
    End date: 2005-02-21

Depakene
    Dosage: 1.5 g daily
    Start date: 2004-11-24
    End date: 2005-02-21

Depakene
    Dosage: 1.6 g daily
    Indication: Partial Seizures
    End date: 2004-11-22

Aspegic 325
    Indication: Influenza Like Illness
    Start date: 2005-02-01

Other drugs received by patient: Levetiracetam; Clobazam; Topiramate; Clonazepam

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014